Clinical Trial Update: Effect of Biphasic Insulin Aspart 30 on Blood Glucose Control in Subjects With Type 2 Diabetes [Phase 3]

View source ↗

Summary

This clinical trial update reports on the Phase 3 evaluation of Biphasic Insulin Aspart 30 for improving blood glucose control in adults with Type 2 diabetes me…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Biphasic insulin aspart 30 (insulin aspart, biphasic 30/70)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED